#weight-loss-medication

[ follow ]
#health-policy

NHS gets 12 years to roll out new weight-loss drug Mounjaro

A new weight-loss jab, Mounjaro, will be rolled out on the NHS, but the implementation may take up to 12 years due to service capacity concerns.

Weight loss jabs not quick fix' for UK worklessness, health experts warn

Weight loss jabs are not a quick fix and can create ethical issues if used to address unemployment.

NHS gets 12 years to roll out new weight-loss drug Mounjaro

A new weight-loss jab, Mounjaro, will be rolled out on the NHS, but the implementation may take up to 12 years due to service capacity concerns.

Weight loss jabs not quick fix' for UK worklessness, health experts warn

Weight loss jabs are not a quick fix and can create ethical issues if used to address unemployment.
morehealth-policy

Novo Nordisk's New Weight Loss Drug Shows Ominous Psychiatric Side Effects

Novo Nordisk's new weight loss drug monlunabant shows promising results but raises concerns due to increased risk of psychiatric side effects compared to placebo.

Eli Lilly slashes prices of weight-loss drug Zepbound for single-use vials

Eli Lilly is introducing lower-cost single-use vials of Zepbound to meet demand and improve accessibility for weight-loss medications.

Meet the teens who have lost weight on Ozempic-like drugs - slimming down to stay alive

Semaglutide has been approved by the FDA for weight loss in obese youngsters 12 and up.
Weight loss medications like Wegovy and Ozempic are being used to help teenagers struggling with obesity.
#wegovy

FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients

Weight-loss drug Wegovy approved to reduce cardiovascular risk in overweight patients.
Wegovy can lower the risk of heart attacks, strokes, and heart-related deaths in patients with obesity.

Wegovy Is Good for More Than Just Weight Loss

Wegovy lowers cardiovascular risks in obese individuals with heart disease by 20%
Obesity drug Wegovy is a significant advancement in weight loss medication

FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients

Weight-loss drug Wegovy approved to reduce cardiovascular risk in overweight patients.
Wegovy can lower the risk of heart attacks, strokes, and heart-related deaths in patients with obesity.

Wegovy Is Good for More Than Just Weight Loss

Wegovy lowers cardiovascular risks in obese individuals with heart disease by 20%
Obesity drug Wegovy is a significant advancement in weight loss medication
morewegovy

Ozempic, weight-loss drugs target angry body-positive influencers for marketing: 'F-k all the way off!'

Body positive creators are being inundated with marketing emails from wellness companies offering weight-loss medication.
The popularity of celebrity-touted weight-loss injectables has led to an increase in demand and the spread of dangerous counterfeit versions.

To keep pounds off, patients may need to continue taking weight loss drug, study suggests

People who take the medication tirzepatide to lose weight will need to continue taking it to maintain weight loss.
The demand for weight loss medications has outstripped manufacturers' capacity, reshaping the economy and causing concern among food sellers.

Taking Ozempic or other weight-loss meds? Watch your diet to avoid exchanging one problem for another'

GLP-1 drugs like Wegovy are helping with weight loss by changing eating habits and increasing satiation.

Ozempic Quiets Food Noise in the BrainBut How?

Weight-loss medication can help in quieting food-related intrusive thoughts and improving eating habits, even when other interventions had failed.
[ Load more ]